The Journal of Nutritional Biochemistry
Volume 15, Issue 9 , Pages 522-526 , September 2004

Effect of the H, K–ATPase inhibitor, esomeprazole magnesium, on gut total antioxidant capacity in mice

  • Timothy R. Koch

      Affiliations

    • Division of Gastroenterology and Hepatology, Medical College of Wisconsin, 9200 West Wisconsin Ave., Milwaukee, WI 53295, USA
    • Corresponding Author InformationCorresponding author. Tel.: (414) 456-6829; fax: (414) 456-6214
    • ,
  • Ann Petro

      Affiliations

    • Department of Surgery, Durham Veterans Affairs Medical Center and Duke University, Durham, NC 27710, USA
    • ,
  • Marcus Darrabie

      Affiliations

    • Department of Surgery, Durham Veterans Affairs Medical Center and Duke University, Durham, NC 27710, USA
    • ,
  • Emmanuel C. Opara

      Affiliations

    • Department of Surgery, Durham Veterans Affairs Medical Center and Duke University, Durham, NC 27710, USA

Received 15 October 2003 ,Revised 23 February 2004 ,Accepted 1 March 2004.

References 

  1. Khaled MA, Sarker SA. Changes of oxidant and antioxidant status in humans due to H. pylori infection. Nutr Res. 1998;18:1463–1468
  2. Drake IM, Mapstone NP, Schorah CJ, White KLM, Chalmers DM, Dixon MF, et al. Reactive oxygen species activity and lipid peroxidation in Helicobacter pylori associated gastritis (relation to gastric mucosal ascorbic acid concentrations and effect of H pylori eradication). Gut. 1998;42:768–771
  3. Farinati F, Libera GD, Cardin R, Molari A, Plebani M, Rugge M, et al. Gastric antioxidant, nitrites, and mucosal lipoperoxidation in chronic gastritis and Helicobacter pylori infection. J Clin Gastroenterol. 1996;22:275–281
  4. Verhulst M-L, Van Oijen AHAM, Roelofs HMJ, Peters WHM, Jansen JBMJ. Antral glutathione concentration and glutathione S-transferase activity in patients with and without Helicobacter pylori. Dig Dis Sci. 2000;45:629–632
  5. Beil W, Obst B, Sewing K-F, Wagner S. Helicobacter pylori reduces intracellular glutathione in gastric epithelial cells. Dig Dis Sci. 2000;45:1769–1773
  6. Wetscher GJ, Hinder RA, Bagchi D, Hinder PR, Bagchi M, Perdikis G, et al. Reflux esophagitis in humans is mediated by oxygen-derived free radicals. Am J Surg. 1995;170:552–557
  7. Lapenna D, de Gioia S, Ciofani G, Festi D, Cuccurullo F. Antioxidant properties of omeprazole. FEBS Lett. 1996;382:189–192
  8. Kawamura T, Miyaji C, Toyabe S, Fukuda M, Watanabe H, Abo T. Suppressive effect of antiulcer agents on granulocytes-a role for granulocytes in gastric ulcer formation. Dig Dis Sci. 2000;45:1786–1791
  9. Wandall JH. Effects of omeprazole on neutrophil chemotaxis, superoxide production, degranulation, and translocation of cytochrome b-245. Gut. 1992;33:617–621
  10. Suzuki M, Mori M, Miura S, Suematsu M, Fukumura D, Kimura H, et al. Omeprazole attenuates oxygen-derived free radical production from human neutrophils. Free Rad Biol Med. 1996;21:727–731
  11. Biswas K, Bandyopadhyay U, Chattopadhyay I, Varadaraj A, Ali E, Banerjee RK. A novel antioxidant and antiapaptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J Biol Chem. 2003;278:10993–11001
  12. Koch TR, Yuan L-X, Petro A, Opara EC. Effects of omeprazole and ascorbate on gastric emptying and anti-oxidant levels in a mouse model of glutathione depletion. Dig Dis Sci. 2002;47:2486–2492
  13. Richter JE, Kahrilas PJ, Johanson J, Maton P, Breiter JR, Hwang C, et al. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis (a randomized controlled trial). Am J Gastroenterol. 2001;96:656–665
  14. Carlsson E, Larsson H, Mattsson H, Ryberg B, Sundell G. Pharmacology and toxicology of omeprazole-with special reference to the effects on the gastric mucosa. Scand J Gastroenterol. 1986;21(suppl 118):31–38
  15. Pellegrini N, Re R, Yang M, Rice-Evans C. Screening of dietary carotenoids and carotenoids-rich fruit extracts for antioxidant activities applying 2,2′-azinobis(3-ethylenebenzothiazoline-6-sulfonic acid radical cation decolorization assay. Methods Enzymol. 1998;299:379–389
  16. Koch TR, Yuan L-X, Stryker SJ, Ratliff P, Telford GL, Opara EC. Total antioxidant capacity of colon in patients with chronic ulcerative colitis. Dig Dis Sci. 2000;45:1814–1819
  17. Abdella N, Al Awadi F, Salman A, Armstrong D. Thiobarbituric acid test as a measure of lipid peroxidation in Arab patients with NIDDM. Diabetes Res. 1990;15:173–177
  18. Ballard TC, Farag A, Branum GD, Akwari OE, Opara EC. Effect of L-glutamine supplementation on impaired glucose regulation during intravenous lipid administration. Nutrition. 1996;12:349–354
  19. Nebot C, Moutet M, Huet P, Xu JZ, Yadan JC, Chaudiere J. Spectrophotometric assay of superoxide dismutase activity based on the activated autooxidation of a tetracyclic catechol. Anal Biochem. 1993;214:442–451
  20. Yu BP. Cellular defenses against damage from reactive oxygen species. Physiol Rev. 1994;74:139–162
  21. Halliwell B, Zhao K, Whiteman M. The gastrointestinal tract (a major site of antioxidant action?). Free Rad Res. 2000;33:819–830
  22. Mowat C, Carswell A, Wirz A, McColl KEL. Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice. Gastroenterology. 1999;116:813–822
  23. Martensson J, Jain A, Meister A. Glutathione is required for intestinal function. Proc Natl Acad Sci USA. 1990;87:1715–1719
  24. Van den Berg R, Haenen GRMM, Van den Berg H, Bast A. Applicability of an improved Trolox equivalent antioxidant capacity measurements of mixtures. Food Chem. 1999;66:511–517
  25. Young IS. Measurement of total antioxidant capacity. J Clin Pathol. 2001;54:339
  26. Cuzzocrea S, Mazzon E, Dugo L, Caputi AP, Riley DP, Salvemini D. Protective effects of M40403, a superoxide dismutase mimetic, in a rodent model of colitis. Eur J Pharmacol. 2001;432:79–89
  27. Lee M, Hyun DH, Halliwell B, Jenner P. Effect of overexpression of wild-type and mutant Cu/Zn–superoxide dismutases on oxidative stress and cell death induced by hydrogen peroxide, 4-hydroxynonenal or serum deprivation (potentiation of injury by ALS-related mutant superoxide dismutases and protection by Bcl-2). J Neurochem. 2001;78:209–220
  28. Lee M, Hyun D, Jenner P, Halliwell B. Effect of overexpression of wild-type and mutant Cu/Zn–superoxide dismutases on oxidative damage and antioxidant defences (relevance to Down's syndrome and familial amyotrophic lateral sclerosis). J Neurochem. 2001;76:957–965

PII: S0955-2863(04)00072-5

doi: 10.1016/j.jnutbio.2004.03.003

The Journal of Nutritional Biochemistry
Volume 15, Issue 9 , Pages 522-526 , September 2004

Article Tools

* Image Usage & Resolution